Edesa Biotech, Inc.
EDSA
$1.96
-$0.075-3.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.59M | -1.62M | -962.10K | -1.67M | -1.86M |
| Total Depreciation and Amortization | 24.50K | 43.10K | 44.20K | 51.40K | 45.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 66.70K | 81.20K | 93.90K | 109.50K | 134.90K |
| Change in Net Operating Assets | -884.00K | -24.20K | -143.10K | 650.80K | 20.80K |
| Cash from Operations | -2.38M | -1.52M | -967.00K | -856.50K | -1.66M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -29.50K |
| Issuance of Common Stock | 6.87M | 626.80K | 0.00 | 138.40K | 275.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 8.34M | 1.54M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -437.50K | -96.00K | -31.40K | -32.40K | -34.50K |
| Cash from Financing | 14.77M | 2.07M | -31.40K | 106.00K | 211.70K |
| Foreign Exchange rate Adjustments | -56.40K | -28.20K | -5.10K | -8.30K | -19.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.33M | 526.20K | -1.00M | -758.70K | -1.47M |